Solid Malignant Neoplasm

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2021-02-05
Clinical Trial Update: Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q) [Phase 2]
A Phase 2 MATCH-subprotocol Q trial evaluating ado-trastuzumab emtansine (T-DM1) for cancers with HER2 genetic changes; results were posted …